Therabionic, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Pancreatic CancerMetastatic Adenocarcinoma
- Interventions
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- THERABIONIC INC.
- Target Recruit Count
- 46
- Registration Number
- NCT05776524
- Locations
- 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Device: TheraBionic DeviceDevice: Placebo DeviceDevice: Quality of Life Assessment
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- THERABIONIC INC.
- Target Recruit Count
- 166
- Registration Number
- NCT04797884
- Locations
- 🇺🇸
DHR Health Advanced Care Center, DHR Oncology Institute, Edinburg, Texas, United States
🇺🇸Tampa General Hospital, Tampa General Cancer Center, Tampa, Florida, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath